Related Experiment Video
Updated: Jun 6, 2025

07:54
Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
Published on: December 21, 2019
6.8K
A Case Report: PSMA PET/CT in Retroperitoneal Hemangioma
Fatema Mohd Al Sawafi1, Olfat Kamel Hasan2, Michael Bonert3
1From the McMaster University, Hamilton, Ontario, Canada.
Clinical Nuclear Medicine
|December 3, 2024
Summary
Prostate-specific membrane antigen (PSMA) PET/CT scans aid prostate cancer staging. A rare case shows a PSMA-avid retroperitoneal hemangioma mimicking cancer recurrence, highlighting diagnostic challenges.
Area of Science:
- Oncology
- Nuclear Medicine
- Radiology
Background:
- Prostate-specific membrane antigen (PSMA) PET/CT has revolutionized prostate cancer detection and staging.
- Rising prostate-specific antigen (PSA) levels post-treatment necessitate accurate restaging.
- PSMA avidity can indicate recurrent or metastatic prostate cancer.

